vitronectin antagonists (Uriach)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namevitronectin antagonists (Uriach)
Drug Alias Namealpha-v/beta-3 integrin antagonists (Uriach)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-V/beta-3 antagonists
TargetsIntegrin alpha-V/beta-3
Therapy Area/IndicationsCoronary RestenosisOsteoporosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUriach Group
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUriach Group
Active IndicationsN/A
Inactive IndicationsCoronary RestenosisOsteoporosisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A